4 terminated. 4 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Terminated 4 |
| Phase 2 | 3 | Terminated 3 |
Follow Scleroderma, Diffuse: new trials by email Literature Review of Scleroderma, Diffuse trials Research Report on Scleroderma, Diffuse
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cardiac Safe Transplants for Systemic Sclerosis Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Terminated | Northwestern University | 9 | 2018-05-17 | 2020-08-12 |
| Trial to Evaluate Efficacy and Safety of Lenabasum in Diffuse Cutaneous Systemic Sclerosis Lenabasum 5 mg, Lenabasum 20 mg, Placebo oral capsule - Diffuse Cutaneous Systemic Sclerosis | Phase 3 | Terminated | Corbus Pharmaceuticals Inc. | 365 | 2017-12-18 | 2021-03-29 |
| Exparel as a Nerve Block for Severe Hand Pain liposomal bupivacaine - CREST Syndrome, Peripheral Vascular Disease | Phase 2 / Phase 3 | Terminated | Jose Soberon, MD | 13 | 2014-11-01 | 2024-05-21 |
| A Clinical Trial for CTD-ILD Treatment N-Acetylcysteine - Interstitial Lung Disease, Connective Tissue Disease | Phase 2 / Phase 3 | Terminated | University of Michigan | 5 | 2011-12-01 | 2017-04-06 |
Arthritis, Rheumatoid (1) · CREST Syndrome (1) · Connective Tissue Diseases (1) · Dermatomyositis (1) · Lung Diseases, Interstitial (1) · Mixed Connective Tissue Disease (1) · Peripheral Vascular Diseases (1) · Polymyositis (1) · Raynaud Disease (1) · Scleroderma, Systemic (1) · Sjogren's Syndrome (1)
Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Connective Tissue Diseases (3) · Scleroderma, Systemic (3) · Arthritis (1) · Autoimmune Diseases (1) · Calcinosis (1) · Calcium Metabolism Disorders (1) · Cardiovascular Diseases (1) · Deglutition Disorders (1) · Digestive System Diseases (1) · Dry Eye Syndromes (1) · Embolism and Thrombosis (1) · Esophageal Diseases (1) · Esophageal Motility Disorders (1)
Acetylcysteine (1) · Antilymphocyte Serum (1) · Cyclophosphamide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Immunoglobulins, Intravenous (1) · Mesna (1) · Methylprednisolone (1) · Methylprednisolone Acetate (1) · Methylprednisolone Hemisuccinate (1) · Octagam (1) · Rituximab (1) · fludarabine (1) · fludarabine phosphate (1) · lenabasum (1)
Corbus Pharmaceuticals Inc. (1) · Jose Soberon, MD (1) · Northwestern University (1) · University of Michigan (1)
United States (4) · Australia (1) · Canada (1) · Germany (1) · Israel (1) · Japan (1) · Netherlands (1) · Poland (1) · South Korea (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Chris Denton, MD (1) · Jose Soberon, MD (1) · Richard Burt, MD (1) · Robert Spiera, MD (1)